Literature DB >> 17603702

Investigation of the toxic effects of ropivacaine corneal endothelium by the impression cytological method.

Sevda Soker1, Sevin Cakmak, Gonul Olmez, Huseyin Buyukbayram, Yusuf Nergiz.   

Abstract

OBJECTIVE: To investigate the toxic effects of ropivacaine on corneal endothelium by using the impression cytological method.
METHODS: The study was performed between October and December 2004 in Dicle University Hospital, Diyarbakir, Turkey. Twenty-four eyes from 12 rats were used for the research. They were divided into 4 groups, each containing 3 different ropivacaine concentrations and a control. Immediately after enucleation, the corneas were excised and the endothelium was exposed to unpreserved ropivacaine 0.01, 0.1, or 1% and balanced salt solutions (BSS) as a control (6 corneas/group) for 20 minutes. The specimens were obtained by impression cytology method and stained with periodic acid shift. Then, they were examined under light microscope.
RESULTS: Blurring at cell membrane borders, vacuolization at cell cytoplasm, hydropic degeneration and increase in toxic granulation were observed in the 1% ropivacaine group. Cytoplasmic hydropic degeneration was determined in the 0.1% ropivacaine group. Cell structures were normal and almost identical to the control group in the 0.01% ropivacaine group.
CONCLUSION: In this study, 2 major conclusions were determined. The impression cytology method can be used in examination of corneal endothelium, and exposure of rat corneal endothelium to 0.01% ropivacaine solutions in vitro appears to be non-toxic.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603702

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  1 in total

1.  Comparative clinical trial of intracameral ropivacaine vs. lignocaine in subjects undergoing phacoemulsification under augmented topical anesthesia.

Authors:  Arun K Sharma; Shalini Singh; Sanjeev Hansraj; Ajai K Gupta; Siddharth Agrawal; Vishal Katiyar; Sanjiv K Gupta
Journal:  Indian J Ophthalmol       Date:  2020-04       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.